| |
Neither APR elevated
|
APR levels discordant
|
Both APR elevated
|
P value
|
|---|
| |
n = 2,520
|
n = 1,058
|
n = 650
| |
|---|
|
mHAQ
|
0.01 ± 0.31
|
-0.03 ± 0.40
|
-0.10 ± 0.43
|
<0.0001
|
|
CDAI
|
-2.40 ± 10.87
|
-3.92 ± 12.37
|
-7.68 ± 14.19
|
<0.0001
|
|
Tender joints
|
-0.69 ± 5.48
|
-1.28 ± 5.81
|
-2.75 ± 6.98
|
<0.0001
|
|
Swollen joints
|
-1.12 ± 5.11
|
-1.49 ± 5.53
|
-2.58 ± 5.95
|
<0.0001
|
|
Patient global assessment
|
-2.38 ± 25.21
|
-4.90 ± 27.78
|
-11.29 ± 30.11
|
<0.0001
|
|
MD global assessment
|
-4.21 ± 17.30
|
-6.45 ± 19.78
|
-12.57 ± 23.19
|
<0.0001
|
- APR, acute phase reactant; mHAQ, modified Health Assessment Questionnaire; CDAI, Clinical Disease Activity Index.
